Related Experiment Video
Updated: Jan 20, 2026
Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles
Published on: April 30, 2019
Biologic Therapy for the Treatment of Giant Cell Arteritis
Rochella A Ostrowski1, Melissa R Bussey1, Rodney Tehrani1
1Division of Allergy, Immunology and Rheumatology.
Abstract:
Giant cell arteritis (GCA), a vasculitis of the medium and large arteries, is traditionally managed with glucocorticoids. However, the side effects of chronic glucocorticoid use and the occurrence of refractory cases warrant the consideration of steroid-sparing agents, including biologic agents. Interleukin-6 (IL-6) inhibition shows the most promise as biologic therapy for refractory cases of GCA, but data to support the use of other existing biologic agents are currently lacking. A better understanding of the pathogenesis of GCA as well as clinical trials investigating both existing and emerging biologic agents is needed to expand therapeutic options for the treatment of GCA.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
10:05Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
Published on: January 25, 2017
Related Concept Videos
02:35Single-Cell Culture of Bacteria Within Giant Vesicles
10:10Synthesis of Compound Giant Unilamellar Vesicles: A Biomimetic Model of Nucleate Cells
03:50A Treatment Protocol for Achilles Tendinopathy with Extracorporeal Shockwave Therapy
07:33Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
10:05Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro